ITGAX and obesity disorder: An interesting finding from our study is that deletion of MyD88 in CD11c+ cells does not affect VAT inflammation aside from the expected decrease in T cell cytokines, which suggests that CD11c+ cell-mediated VAT inflammation in obesity is MyD88-independent.